These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38653825)

  • 21. α-Substituted Lactams and Acetamides: Ion Channel Modulators that Show Promise in Treating Drug-resistant Epilepsy.
    Krivoshein AV
    Cent Nerv Syst Agents Med Chem; 2020; 20(2):79-87. PubMed ID: 32386500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.
    Wilcox KS; West PJ; Metcalf CS
    Neuropharmacology; 2020 Apr; 166():107811. PubMed ID: 31790717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
    Campos G; Fortuna A; Falcão A; Alves G
    Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into Potential Targets for Therapeutic Intervention in Epilepsy.
    Zavala-Tecuapetla C; Cuellar-Herrera M; Luna-Munguia H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.
    Barker-Haliski ML; Johnson K; Billingsley P; Huff J; Handy LJ; Khaleel R; Lu Z; Mau MJ; Pruess TH; Rueda C; Saunders G; Underwood TK; Vanegas F; Smith MD; West PJ; Wilcox KS
    Neurochem Res; 2017 Jul; 42(7):1904-1918. PubMed ID: 28303498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-resistant epilepsy: Drug target hypothesis and beyond the receptors.
    Fonseca-Barriendos D; Frías-Soria CL; Pérez-Pérez D; Gómez-López R; Borroto Escuela DO; Rocha L
    Epilepsia Open; 2022 Aug; 7 Suppl 1(Suppl 1):S23-S33. PubMed ID: 34542940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacological basis of herbal medicines for epilepsy.
    Sucher NJ; Carles MC
    Epilepsy Behav; 2015 Nov; 52(Pt B):308-18. PubMed ID: 26074183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
    Löscher W; Potschka H; Sisodiya SM; Vezzani A
    Pharmacol Rev; 2020 Jul; 72(3):606-638. PubMed ID: 32540959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiepileptic drug effects on mood and behavior: molecular targets.
    Perucca P; Mula M
    Epilepsy Behav; 2013 Mar; 26(3):440-9. PubMed ID: 23092694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.
    Zaitsev AV; Smolensky IV; Jorratt P; Ovsepian SV
    CNS Drugs; 2020 Nov; 34(11):1089-1103. PubMed ID: 32926322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A resurging boom in new drugs for epilepsy and brain disorders.
    Younus I; Reddy DS
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):27-45. PubMed ID: 28956955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies.
    Ibhazehiebo K; Rho JM; Kurrasch DM
    Neuropharmacology; 2020 May; 167():107988. PubMed ID: 32070912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoresponsiveness of spontaneous recurrent seizures and the comorbid sleep disorder of epileptic Kcna1-null mice.
    Deodhar M; Matthews SA; Thomas B; Adamian L; Mattes S; Wells T; Zieba B; Simeone KA; Simeone TA
    Eur J Pharmacol; 2021 Dec; 913():174656. PubMed ID: 34838797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selected flavonoids and their role in the treatment of epilepsy - a review of the latest reports from experimental studies.
    Szala-Rycaj J; Zagaja M; Szewczyk A; Andres-Mach M
    Acta Neurobiol Exp (Wars); 2021; 81(2):151-160. PubMed ID: 34170262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.
    Kaminski RM; Rogawski MA; Klitgaard H
    Neurotherapeutics; 2014 Apr; 11(2):385-400. PubMed ID: 24671870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
    Golub V; Ramakrishnan S; Reddy DS
    Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunct antiseizure effect of clotrimazole in a rotenone corneal kindling mouse model of mitochondrial drug-resistant epilepsy.
    Kaur A; Kumar S; Goel RK
    Epilepsy Res; 2023 Dec; 198():107246. PubMed ID: 37925976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
    Abdelsayed M; Sokolov S
    Channels (Austin); 2013; 7(3):146-52. PubMed ID: 23531742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.